Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YDR2 | ISIN: US5845071076 | Ticker-Symbol: N/A
1-Jahres-Chart
MEDICAL CARE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
MEDICAL CARE TECHNOLOGIES INC 5-Tage-Chart
ACCESS Newswire
387 Leser
Artikel bewerten:
(2)

Medical Care Technologies Inc. Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission

With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform.

MESA, ARIZONA / ACCESS Newswire / September 11, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that its subsidiary Infinite Auctions LLC has amassed a sports memorabilia and trading card inventory valued at approximately $2.54 million, based on recent comps and fair market valuations.

Highlights include a LeBron James 2016 Game-Worn NBA Finals Jersey, valued at nearly $1,000,000 based on the recent sale of a jersey from the same Finals series, and a Tom Brady 1/1 sports card that could carry a fair market value in the hundreds of thousands of dollars, supported by a recent comp sale of a similar card for nearly $500,000.

Infinite Auctions has also delivered a tremendous revenue boost through private sports card sales outside of its auctions, proving its ability to generate cash flow across multiple sales channels. Combined with rising auction revenues, these appreciating and highly liquid assets provide a robust financial foundation.

This financial strength directly supports MDCE's broader corporate mission of pioneering AI-powered healthcare diagnostics. The Company is currently developing patent-pending solutions across multiple verticals - including mental health tracking, wound monitoring, mole and melanoma detection, and health risk estimation - all designed to detect chronic or life-threatening conditions earlier and save lives. By reinforcing balance sheet flexibility through Infinite Auctions, MDCE is better positioned to fund ongoing R&D, strengthen its intellectual property portfolio, and accelerate the path toward commercialization of its AI healthcare platform.

"We're building value in two powerful arenas: sports memorabilia and healthcare innovation," said Marshall Perkins, CEO of MDCE. "High-value assets like the LeBron Finals jersey and Brady 1/1 card strengthen Infinite Auctions' market position while also giving MDCE the financial flexibility to complete our mission of revolutionizing preventive healthcare with AI-driven diagnostics."

The global sports memorabilia market, valued at $26.1 billion in 2021, is projected to surpass $40 billion by 2030(Market Decipher). This market synergy - pairing Infinite Auctions' growing asset-backed strength with MDCE's healthcare innovation - gives the Company both near-term revenue momentum and long-term transformational potential.


About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink: MDCE) is a diversified holding company with three subsidiaries-Infinite Auctions LLC, Real Game Used LLC, and its healthcare technology division. MDCE is pioneering AI-driven health diagnostics through patent-pending applications designed to detect early warning signs of chronic and life-threatening conditions, empowering earlier intervention and improved patient outcomes. Through Infinite Auctions and Real Game Used, MDCE is also capitalizing on the multi-billion-dollar sports memorabilia and authentication market, creating a unique synergy of financial growth and healthcare innovation.

For more information, visit: www.medicalcaretechnologies.com


Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding future events, including without limitation, development, regulatory approval, commercialization, and market acceptance of our products, as well as estimates of market opportunity, revenue potential, and impact, are forward-looking statements. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that may cause such differences include those discussed in the Company's reports filed with OTC Markets. The Company undertakes no obligation to update any forward-looking statements, except as required by law.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medical-care-technologies-inc.-otc-pink-mdce-subsidiary-infinite-auct-1071679

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.